Antidepressant-like effect of bright light is potentiated by L-serine administration in a mouse model of seasonal affective disorder

Brain Research Bulletin
Misato KawaiShinobu Yasuo

Abstract

Bright light therapy is used as the primary treatment for seasonal affective disorder; however, the mechanisms underlying its antidepressant effect are not fully understood. Previously, we found that C57BL/6J mice exhibit increased depression-like behavior during a short-day condition (SD) and have lowered brain serotonin (5-HT) content. This study analyzed the effect of bright light on depression-like behaviors and the brain serotonergic system using the C57BL/6J mice. In the mice maintained under SD, bright light treatment (1000 lx, daily 1 h exposure) for 1 week reduced immobility time in the forced swimming test and increased intake of saccharin solution in a saccharin intake test. However, the light treatment did not modify 5-HT content and selective 5-HT uptake in the amygdala, or temporal patterns of core body temperature and wheel-running activity throughout a day. In the next experiment, we attempted to enhance the effect of bright light by using L-serine, a precursor of D-serine that acts as an N-methyl-D-aspartic acid receptor coagonist. Daily subcutaneous injection of L-serine for 2 weeks prior to the bright light strongly reduced the immobility time in the forced swimming test, suggesting a synergistic effect of li...Continue Reading

References

Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Jan 16, 1987·Science·A J LewyT M Hoban
Nov 1, 1982·The American Journal of Psychiatry·A J LewyT A Wehr
Oct 26, 1999·The Journal of Comparative Neurology·K V FiteL Bengston
May 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eric R StevensRobert F Miller
Jan 15, 2005·Brain Research·Katherine V FiteAndrew Bellemer
Feb 22, 2005·Psychoneuroendocrinology·Brian J Prendergast, Randy J Nelson
Sep 15, 2005·Neuroscience and Biobehavioral Reviews·Julie G Hensler
Jun 1, 2006·The Journal of Comparative Neurology·Samer HattarDavid M Berson
Sep 21, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthäus WilleitErnst A Singer
Mar 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·M M C Gonzalez, G Aston-Jones
Sep 3, 2008·Archives of General Psychiatry·Nicole Praschak-RiederJeffrey H Meyer
May 10, 2011·Journal of Chemical Neuroanatomy·Mariano Soiza-Reilly, Kathryn G Commons
Aug 4, 2011·Neuropsychobiology·Gerald PailSiegfried Kasper
Jan 9, 2014·Chronobiology International·Mark A Oldham, Domenic A Ciraulo

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.